In vitro anticancer activity of cis-diammineplatinum(II) complexes with β-diketonate leaving group ligands
about
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) ProdrugsLipid-Based Drug Delivery Systems in Cancer Therapy: What Is Available and What Is Yet to Come.Antitumor activity of [Pt(O,O'-acac)(γ-acac)(DMS)] in mouse xenograft model of breast cancer.Oxidative DNA double strand breaks and autophagy in the antitumor effect of sterically hindered platinum(II) complexes in NSCLCsTargeting mitochondrial DNA with a platinum-based anticancer agent.Synthesis, characterization, and evaluation of cis-diphenyl pyridineamine platinum(II) complexes as potential anti-breast cancer agentsSynthetic methods for the preparation of platinum anticancer complexes.Exploring Intein Inhibition by Platinum Compounds as an Antimicrobial Strategy.Mononuclear iron(iii) complexes of tridentate ligands with efficient nuclease activity and studies of their cytotoxicity.DNA binding, antitumor activities, and hydroxyl radical scavenging properties of novel oxovanadium (IV) complexes with substituted isoniazid.Photoactive platinum(ii) β-diketonates as dual action anticancer agents.Bifunctional Platinum(II) Complexes with Bisphosphonates Substituted Diamine Derivatives: Synthesis and In vitro Cytotoxicity.Combining imaging and anticancer properties with new heterobimetallic Pt(ii)/M(i) (M = Re, 99mTc) complexes.The development of ruthenium(ii) polypyridyl complexes and conjugates for in vitro cellular and in vivo applications.β-Keto-enol Tethered Pyridine and Thiophene: Synthesis, Crystal Structure Determination and Its Organic Immobilization on Silica for Efficient Solid-Liquid Extraction of Heavy Metals.
P2860
Q28066801-93C952E3-CB8B-48C9-8338-5D1544A3990FQ30366990-B090E90E-B7AC-4F3E-92FD-21F44FE24979Q33695015-0FCFCD36-DDFB-487A-B9B6-D76DC88B2D38Q33761590-3279CA45-00A4-401D-A000-FD93918F0D83Q33847450-DD3F36DF-219B-4A92-A2B4-3EADDB326809Q36270717-1CDE3BC4-C288-4217-9C7E-27FFF74E0E89Q37722632-AD615DE7-F53F-4684-A94C-74EF91A424DAQ38823110-912258A1-1070-4407-9367-A0DC5AADA114Q38829453-EEBC7509-4300-4F5B-B02C-706BB17C4033Q39090080-80302976-B143-4255-B41B-5C169B91DD8EQ46506519-C72F3158-98D0-427D-B405-62C403AA8638Q47603642-F146FF79-8B9A-4CFF-A517-E5322C8A414DQ48843560-4EF9DBF2-C2E4-42B1-9D35-1BFA251D5FC3Q49611544-2B090353-842A-44DE-A9E7-41AEFD5BDDC6Q53063701-1F9F36CB-9B1E-45D9-97C3-B68492F58888
P2860
In vitro anticancer activity of cis-diammineplatinum(II) complexes with β-diketonate leaving group ligands
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
In vitro anticancer activity o ...... ketonate leaving group ligands
@ast
In vitro anticancer activity o ...... ketonate leaving group ligands
@en
type
label
In vitro anticancer activity o ...... ketonate leaving group ligands
@ast
In vitro anticancer activity o ...... ketonate leaving group ligands
@en
prefLabel
In vitro anticancer activity o ...... ketonate leaving group ligands
@ast
In vitro anticancer activity o ...... ketonate leaving group ligands
@en
P2860
P356
P1476
In vitro anticancer activity o ...... ketonate leaving group ligands
@en
P2093
Stephen J Lippard
P2860
P304
P356
10.1021/JM3002857
P407
P577
2012-05-18T00:00:00Z